NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP
Elevance Health, Inc. ELV
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY12 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$199.1B
▲ 12.5% vs FY2024
Dividend streak
12 yrs
Raised every year since 2014
EPS · FY25
$25.21
Dividend / sh · FY25
—
Payout · FY25
27%
ROE · FY25
13.3%
Net margin · FY25
2.8%
Dividend coverage
4.3×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 199.1B
Revenue, FY2025 · full 19-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
USD 25.21
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 4.3 times — the rest stayed in the company.
Profitability
13.3%
Return on equity, FY2025
ROE
Operating margin3.6%
Net margin2.8%
Return on assets4.8%
Each USD of equity produced 13 cents of profit this year.
Returned to shareholders
USD 4.1B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 1.5B
Net buybacksUSD 2.6B
Share of profit72.1%
Consecutive raises12 years
USD 1.5B in dividends and USD 2.6B in buybacks — 72% of the year's profit went back to shareholders.
Growth
+10.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+8.3%
+10.3%
+9.7%
+8.5%
Net income
−1.3%
+4.4%
+8.3%
+4.6%
EPS, diluted
+1.3%
+7.0%
+10.4%
+9.0%
Dividend / share
+15.9%
+14.6%
+14.7%
Returned to shareholders
+6.0%
+3.3%
+7.5%
−0.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.22B
Shares outstanding, FY2025
Change, 5 years−10.1%
Change, 10 years−15.5%
The share count shrank 10% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 121.5B
total assets, end of FY2025
Total assetsUSD 121.5B
EquityUSD 43.9B
CashUSD 9.5B
Gross debtUSD 31.9B
Net debtUSD 22.4B
Current ratio1.54×
Net debt stands at 51% of equity.
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
199.1
177.0
171.3
156.6
138.6
121.9
104.2
92.1
90.0
84.9
79.2
73.9
71.0
61.5
60.7
58.7
64.9
61.3
61.2
Operating income $B
7.2
7.9
8.5
8.3
7.6
6.4
6.0
5.4
4.2
4.8
4.8
4.4
4.0
3.6
3.8
4.1
4.2
4.3
·
EBITDA $B
8.7
9.3
10.2
10.0
8.9
7.5
7.1
6.6
4.3
4.9
4.9
4.5
4.1
3.7
3.9
4.2
4.3
4.5
·
Income tax $B
1.0
1.9
1.7
1.7
1.8
1.7
1.2
1.3
0.1
2.1
2.1
1.8
1.2
1.2
1.3
1.5
2.7
0.6
1.9
Net income $B
5.7
6.0
6.0
5.9
6.2
4.6
4.8
3.8
3.8
2.5
2.6
2.6
2.5
2.7
2.6
2.9
4.7
2.5
3.3
EPS, diluted $
25.21
25.68
25.22
24.28
24.95
17.98
18.47
14.19
14.35
9.21
9.38
8.99
8.20
8.18
7.25
6.94
9.88
4.76
5.56
Dividend / sh $
·
·
5.92
5.12
4.52
3.80
3.20
3.00
2.70
2.60
2.50
1.75
1.50
1.15
1.00
0.00
·
·
·
Payout %
27
25
23
21
18
21
17
21
18
28
26
19
18
14
14
0
·
·
·
ROE %
13.3
14.8
15.8
16.3
17.8
14.1
16.0
13.6
14.9
10.3
10.8
10.5
10.3
11.3
11.2
11.9
20.5
11.2
14.6
Shares out B
0.22
0.23
0.23
0.24
0.24
0.25
0.25
0.26
0.26
0.26
0.26
0.27
0.29
0.30
0.34
0.38
0.45
0.50
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
54 of 54
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed